Data as of Nov 9, 2026

216.101.17.0/24

No anonymizer space · no proxy exits in 30 days

Theravance Biopharma US, LLC · space held by AT&T Enterprises, LLC

Announcement
this exact prefix
No RPKI
Announced by
Type
Business
Risk
0 / 100 · Low

Announcements

Less specific

Covering announcements

PrefixOriginTypeProxy exitsHolderRPKI
216.100.0.0/14
since Nov 2021
AS7018Residential917
47 always on
AT&T Enterprises, LLC

Registrations in this block

The registry's network records over the announcement: those covering it, widest first, then every record inside it, under its parent.

RangeAddressesNetnameHolderTypeCreatedAbuse contact
216.100.0.0/14262,144SBCIS-SIS80AT&T Enterprises, LLC (AEL-360) · USDirect AllocationOct 2, 1998abuse@att.net
└ 216.101.17.0/24256216-101-17-0-1Theravance Biopharma US, LLC (TBU-3) · USReassignedJun 25, 2019achan@theravance.com

Network & registry

IPv4 market

Holder

Organization
AT&T Enterprises, LLC
Handle
AEL-360
Range
216.100.0.0/14
Registration type
Direct Allocation
Record created
Oct 2, 1998
Origin network

AS14421

US
Name
Theravance Biopharma US, LLC
Type
Business
Registered
Dec 9, 1999
Domain
theravance.com
Industry
Chemical and Pharmaceutical Manufacturing
Spamhaus ASN-DROP
not listed